학술논문

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.
Document Type
Article
Source
Nature Communications; 12/19/2017, Vol. 8 Issue 1, p1-12, 12p
Subject
CHRONIC lymphocytic leukemia
IBRUTINIB
IMMUNOTHERAPY
TRANSCRIPTOMES
DRUG resistance
Language
ISSN
20411723
Abstract
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)